Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | AMGN | REGN | VRTX | GILD |
| Company | Akero Therapeutics Inc | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 28.13 | 320.95 | 1,011.56 | 467.49 | 85.83 |
| High | 29.16 | 322.57 | 1,013.91 | 477.00 | 85.94 |
| Low | 27.91 | 318.75 | 998.17 | 464.85 | 84.59 |
| Last | 29.08 | 321.01 | 999.02 | 476.15 | 84.67 |
| Change | +0.57 | -1.40 | -13.17 | +8.18 | -1.47 |
| % Change | +2.00% | -0.43% | -1.30% | +1.75% | -1.71% |
| Volume | 351,300 | 1,254,500 | 510,900 | 1,083,300 | 3,814,800 |
| 20-Day Average Volume | 533,895 | 2,043,520 | 714,465 | 1,023,290 | 7,175,150 |
| Previous Close | 28.51 | 322.41 | 1,012.19 | 467.97 | 86.14 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.05 | 325.29 | 1,065.87 | 467.07 | 83.96 |
| 20-Day Raw Stochastic | 81.10% | 32.77% | 3.50% | 67.02% | 58.77% |
| 20-Day Relative Strength | 57.34% | 46.99% | 32.49% | 52.99% | 63.10% |
| Weighted Alpha | +77.98 | +13.71 | +13.43 | +26.37 | +16.27 |
| Today's Opinion | 100% Buy | 40% Buy | 24% Sell | 40% Buy | 100% Buy |
| Previous Opinion | 96% Buy | 40% Buy | 8% Sell | 8% Buy | 100% Buy |
| Last Month's Opinion | 72% Buy | 88% Buy | 80% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.17% since 10/03/24 | +1.11% since 10/03/24 | -1.53% since 10/03/24 | +4.98% since 10/03/24 | +0.59% since 10/03/24 |
| Low | 26.46 on 10/07/24 | 314.70 on 10/09/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 83.98 on 10/04/24 |
| High | 29.16 on 10/10/24 | 322.99 on 10/09/24 | 1,023.09 on 10/04/24 | 477.00 on 10/10/24 | 86.85 on 10/09/24 |
| 1-Month | |||||
| %Chg | +12.98% since 09/10/24 | -2.41% since 09/10/24 | -12.09% since 09/10/24 | +1.14% since 09/10/24 | +3.97% since 09/10/24 |
| Low | 25.01 on 09/11/24 | 312.16 on 09/25/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 79.64 on 09/11/24 |
| High | 29.87 on 09/27/24 | 339.17 on 09/23/24 | 1,170.58 on 09/13/24 | 490.15 on 09/16/24 | 86.85 on 10/09/24 |
| 3-Month | |||||
| %Chg | +21.17% since 07/10/24 | -0.21% since 07/10/24 | -6.73% since 07/10/24 | -3.15% since 07/10/24 | +23.16% since 07/10/24 |
| Low | 22.84 on 08/05/24 | 306.59 on 08/07/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 68.14 on 07/11/24 |
| High | 29.87 on 09/27/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 86.85 on 10/09/24 |
| 6-Month | |||||
| %Chg | +32.79% since 04/10/24 | +20.48% since 04/10/24 | +6.71% since 04/10/24 | +19.76% since 04/10/24 | +24.30% since 04/10/24 |
| Low | 17.86 on 06/05/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 62.07 on 05/31/24 |
| High | 29.87 on 09/27/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 86.85 on 10/09/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,971,495 | 172,952,000 | 111,529,160 | 120,761,072 | 107,317,776 |
| Shares Outstanding, K | 69,151 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -151,760,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | -55,990,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | -0.25 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.81 on 08/09/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.08 | 26.17 | 0.00 | 18.13 |